End-of-day quote
Shenzhen S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
21
CNY
|
+0.33%
|
|
+3.91%
|
+22.59%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
31,273
|
62,525
|
68,086
|
44,805
|
40,498
|
50,078
|
-
|
-
|
Enterprise Value (EV)
1 |
34,394
|
66,450
|
71,641
|
51,994
|
55,428
|
52,031
|
52,405
|
50,078
|
P/E ratio
|
11.9
x
|
27.2
x
|
13.5
x
|
13.1
x
|
12.7
x
|
12.3
x
|
10.4
x
|
8.95
x
|
Yield
|
4.87%
|
3.28%
|
4.02%
|
-
|
-
|
5.91%
|
6.62%
|
7.69%
|
Capitalization / Revenue
|
2.75
x
|
4.43
x
|
3.31
x
|
1.86
x
|
1.51
x
|
1.62
x
|
1.44
x
|
1.39
x
|
EV / Revenue
|
3.03
x
|
4.71
x
|
3.48
x
|
2.16
x
|
2.07
x
|
1.68
x
|
1.51
x
|
1.39
x
|
EV / EBITDA
|
8.56
x
|
16.8
x
|
10.2
x
|
8.98
x
|
8.58
x
|
6.43
x
|
5.91
x
|
5.14
x
|
EV / FCF
|
-
|
-
|
45.3
x
|
-39.4
x
|
113
x
|
6.43
x
|
15
x
|
9.3
x
|
FCF Yield
|
-
|
-
|
2.21%
|
-2.54%
|
0.88%
|
15.5%
|
6.68%
|
10.8%
|
Price to Book
|
2.25
x
|
4.4
x
|
3.6
x
|
2.17
x
|
1.82
x
|
2.08
x
|
1.86
x
|
1.58
x
|
Nbr of stocks (in thousands)
|
2,032,021
|
2,032,021
|
2,381,470
|
2,368,139
|
2,364,177
|
2,384,670
|
-
|
-
|
Reference price
2 |
15.39
|
30.77
|
28.59
|
18.92
|
17.13
|
21.00
|
21.00
|
21.00
|
Announcement Date
|
28/02/20
|
15/04/21
|
12/04/22
|
27/04/23
|
23/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,359
|
14,108
|
20,566
|
24,113
|
26,765
|
30,896
|
34,733
|
35,997
|
EBITDA
1 |
4,018
|
3,960
|
7,040
|
5,788
|
6,459
|
8,094
|
8,870
|
9,746
|
EBIT
1 |
3,050
|
2,831
|
5,554
|
4,086
|
3,917
|
4,931
|
5,866
|
6,788
|
Operating Margin
|
26.86%
|
20.07%
|
27%
|
16.94%
|
14.64%
|
15.96%
|
16.89%
|
18.86%
|
Earnings before Tax (EBT)
1 |
3,022
|
2,820
|
5,519
|
4,073
|
3,917
|
4,847
|
5,749
|
6,681
|
Net income
1 |
2,594
|
2,289
|
4,676
|
3,419
|
3,226
|
4,063
|
4,818
|
5,598
|
Net margin
|
22.84%
|
16.22%
|
22.74%
|
14.18%
|
12.05%
|
13.15%
|
13.87%
|
15.55%
|
EPS
2 |
1.290
|
1.130
|
2.120
|
1.440
|
1.350
|
1.701
|
2.019
|
2.348
|
Free Cash Flow
1 |
-
|
-
|
1,580
|
-1,321
|
490.2
|
8,088
|
3,500
|
5,384
|
FCF margin
|
-
|
-
|
7.68%
|
-5.48%
|
1.83%
|
26.18%
|
10.08%
|
14.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
22.44%
|
-
|
7.59%
|
99.92%
|
39.46%
|
55.24%
|
FCF Conversion (Net income)
|
-
|
-
|
33.78%
|
-
|
15.19%
|
199.07%
|
72.64%
|
96.18%
|
Dividend per Share
2 |
0.7500
|
1.010
|
1.150
|
-
|
-
|
1.240
|
1.391
|
1.614
|
Announcement Date
|
28/02/20
|
15/04/21
|
12/04/22
|
27/04/23
|
23/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
5,297
|
6,068
|
6,332
|
5,630
|
6,083
|
6,276
|
7,014
|
6,503
|
-
|
8,367
|
8,530
|
8,225
|
-
|
-
|
EBITDA
1 |
1,346
|
1,717
|
1,769
|
1,480
|
-
|
-
|
-
|
-
|
-
|
1,721
|
1,786
|
1,615
|
-
|
-
|
EBIT
1 |
1,012
|
1,294
|
1,447
|
1,070
|
274.9
|
812.5
|
1,125
|
1,232
|
-
|
1,303
|
1,368
|
1,198
|
-
|
-
|
Operating Margin
|
19.11%
|
21.32%
|
22.86%
|
19%
|
4.52%
|
12.95%
|
16.04%
|
18.95%
|
-
|
15.58%
|
16.04%
|
14.56%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
994.9
|
1,292
|
1,443
|
1,066
|
271.6
|
818
|
1,125
|
1,226
|
-
|
1,248
|
1,265
|
1,094
|
-
|
-
|
Net income
1 |
845.6
|
1,064
|
1,202
|
907
|
246.1
|
682.6
|
880
|
1,084
|
-
|
1,036
|
1,048
|
882.9
|
-
|
-
|
Net margin
|
15.96%
|
17.54%
|
18.98%
|
16.11%
|
4.05%
|
10.88%
|
12.55%
|
16.68%
|
-
|
12.38%
|
12.28%
|
10.73%
|
-
|
-
|
EPS
2 |
0.2600
|
0.4500
|
0.5600
|
0.4000
|
0.0300
|
0.2800
|
0.3700
|
0.4600
|
-
|
0.4340
|
0.4391
|
0.3700
|
-
|
-
|
Dividend per Share
2 |
-
|
1.000
|
-
|
0.2000
|
-
|
-
|
-
|
-
|
0.6000
|
0.3747
|
0.3747
|
0.3747
|
0.3747
|
0.3747
|
Announcement Date
|
12/04/22
|
19/04/22
|
19/08/22
|
24/10/22
|
27/04/23
|
25/08/23
|
13/10/23
|
23/04/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,121
|
3,925
|
3,555
|
7,189
|
14,929
|
1,953
|
2,327
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7766
x
|
0.9912
x
|
0.5049
x
|
1.242
x
|
2.312
x
|
0.2413
x
|
0.2623
x
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,580
|
-1,321
|
490
|
8,088
|
3,500
|
5,384
|
ROE (net income / shareholders' equity)
|
19.5%
|
16.2%
|
27.1%
|
16.7%
|
14.6%
|
16.5%
|
18.6%
|
17.8%
|
ROA (Net income/ Total Assets)
|
11.1%
|
7.54%
|
11.7%
|
-
|
-
|
5.93%
|
6.71%
|
7.7%
|
Assets
1 |
23,432
|
30,358
|
40,051
|
-
|
-
|
68,475
|
71,787
|
72,701
|
Book Value Per Share
2 |
6.830
|
6.990
|
7.940
|
8.710
|
9.420
|
10.10
|
11.30
|
13.30
|
Cash Flow per Share
2 |
0.9900
|
1.540
|
1.820
|
1.340
|
1.430
|
4.160
|
3.590
|
3.920
|
Capex
1 |
995
|
935
|
2,749
|
4,518
|
2,914
|
2,714
|
3,078
|
2,192
|
Capex / Sales
|
8.76%
|
6.62%
|
13.36%
|
18.74%
|
10.89%
|
8.79%
|
8.86%
|
6.09%
|
Announcement Date
|
28/02/20
|
15/04/21
|
12/04/22
|
27/04/23
|
23/04/24
|
-
|
-
|
-
|
Average target price
23.02
CNY Spread / Average Target +9.64% Consensus |
1st Jan change
|
Capi.
|
---|
| +22.59% | 6.92B | | +14.70% | 64.83B | | -1.61% | 46.29B | | +14.58% | 40.05B | | +20.84% | 26.72B | | +1.16% | 17.45B | | -21.87% | 15.82B | | +1.11% | 15.02B | | -11.34% | 14.73B | | -20.82% | 13.34B |
Other Specialty Chemicals
|